Tech Company Financing Transactions
Efferon Funding Round
On 5/21/2026, Efferon raised $2.9 million in Seed investment from private investors.
Transaction Overview
Company Name
Announced On
5/21/2026
Transaction Type
Venture Equity
Amount
$2,900,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the expansion of its U.S. office and strengthen the local team.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Hans-Gasser-Platz
Villach, Carinthia, 9500
Austria
Villach, Carinthia, 9500
Austria
Phone
Undisclosed
Website
Email Address
Overview
Efferon is an innovative European biotech company founded in 2016 that specializes in developing and manufacturing next-generation extracorporeal blood purification (hemoadsorption) technologies. The company focuses on designing advanced therapeutic devices to treat critical, life-threatening conditions in intensive care units (ICUs), specifically sepsis, septic shock, multiple organ failure syndrome, and severe cytokine storms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dima Romashin
Browse more venture capital transactions:
Prev: 5/21/2026: CVRD Health venture capital transaction
Next: 5/21/2026: PteroDynamics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs